top of page

Treating ADHD in females to address the Maternal Mental Health Crisis

How will treating ADHD in females help address Maternal Mental Health Crisis?


Who’s more likely to develop hormonal mediated mood disorders? Research indicates that females with ADHD are at a significantly higher risk. This vulnerability becomes particularly pronounced during pivotal life stages such as adolescence, peripartum and perimenopausal periods. These stages often coincide with drastic hormonal fluctuations that can exacerbate pre-existing ADHD symptoms, leading to a deterioration in mental health. In fact, we are witnessing a concerning trend where postpartum and perimenopausal women are being diagnosed with ADHD at alarming rates, often because they can no longer manage their untreated ADHD symptoms amidst the added stressors of motherhood and life transitions.


Woman in glasses receives car keys from gloved hand through a car window, smiling. She wears a gray suit. Background shows buildings.
Women with ADHD have an increased risk of motor vehicle accidents. Treating ADHD reverses this risk.

Recently, a postpartum therapist reached out to me with a query about whether she should venture into the ADHD space, and my response was a resounding yes. The reality is that addressing ADHD appropriately in females, particularly those navigating the complexities of motherhood and hormonal changes, is likely one of the most effective strategies for tackling the broader maternal mental health crisis that is currently affecting so many women. By recognizing and treating AD

HD in this demographic, we can help mitigate the risk of developing more severe mood disorders, which are often exacerbated by the hormonal changes that accompany pregnancy and menopause. The implications of this are profound.


Not only does it highlight the need for increased awareness and understanding of ADHD in women, but it also underscores the importance of tailored therapeutic approaches that consider the unique challenges faced by these individuals. By creating supportive environments and providing appropriate treatment options, we can empower women to manage their symptoms effectively, leading to better mental health outcomes for both themselves and their families. This approach not only benefits the individual but has the potential to create a ripple effect, positively impacting maternal mental health on a larger scale. The intersection of ADHD and female hormonal health is a critical area that deserves more attention and resources, as the well-being of mothers is intrinsically linked to the well-being of their children and families.





Comments


Tally Reproductive Psychiatrist, LLC

Private Practice of Jamie Sorenson, MD

3689 Coolidge Court Unit 5

Tallahassee, FL 32311

Call or Text: 850-694-2008

Fax: (786) 590-1485

Email: info@tallyrepropsych.com

Online Scheduling:

https://tallyrepropsych.clientsecure.me/

  • Youtube
  • Instagram
  • Threads
  • TikTok
  • Facebook
  • Linkedin

Telemedicine appointments available only in: Florida, Georgia, Tennessee, and Colorado 

If you are experiencing thoughts of self-harm or are in crisis, please do not use this website. Instead, call or text 988 to reach the Suicide and Crisis Lifeline, or go to your nearest emergency department. If you are outside the United States, please contact your local emergency number.

Conditions Dr. Sorenson has expertise in:

  • Attention Deficit Hyperactivity Disorder (ADHD)

  • Autism Spectrum Disorder (ASD)

  • Obsessive Compulsive Disorder (OCD)

  • Depression or Major Depressive Disorder (MDD)

  • Anxiety or Generalized Anxiety Disorder (GAD)

  • Panic Disorder with and without agorophobia

  • Bipolar Disorder

  • Bipolar 2 Disorder

  • Post Traumatic Stress Disorder (PTSD)

  • Chronic Post Traumatic Stress Disorder (CPTSD)

  • Premenstrual Dysphoric Disorder (PMDD) or Premenstrual Exacerbation of a mood disorder (PME)

  • Perinatal Depression and Postpartum Depression

  • Perinatal Anxiety and Postpartum Anxiety

  • Perinatal OCD and Postpartum OCD

  • Perinatal Psychosis and Postpartum Psychosis

  • Perimenopause/Menopause Mood and Anxiety Disorders

  • Perimenopause/Menopause Cognitive Disorders

  • Gender Dysphoria

  • LGBTQI Mental Health

  • Mood and anxiety disorders while undergoing infertility treatments

Comorbidities not directly treated by Dr. Sorenson that will routinely be considered in your individualized treatment plan and recommendations:

  • Ehlers-Danlos Syndrome

  • Hypermobility Spectrum Disorders

  • Mast Cell Activation Syndrome (MCAS)

  • Postural Orthostatic Tachycardia Syndrome (POTS), dysautonomia, and Mitral Valve Prolapse

  • Fibromyalgia 

  • Chronic Pain

  • Chronic Fatigue Syndrome (CFS)

  • Insomnia and Sleep Apnea

  • Narcolepsy and Idiopathic Hypersomnia

  • Chiari Malformation

  • Small Fiber Neuropathy

  • Pelvic organ prolapse, incontinence, chronic pelvic pain, pelvic floor dysfunction, hernias

  • Irritable Bowel Syndrome (IBS), gastroparesis, gut dysmotility

  • Bladder Pain Syndrome (previously interstitial cystitis)

  • Osteoporosis/Osteopenia

  • Dental Problems/TMJ

  • Migraines and Headaches​

  • Hormone Replacement Therapy (HRT)

  • Infertility Treatment

  • Endometriosis 

  • Polycystic Ovarian Syndrome (PCOS)

  • Thyroid Disorders: Hypothyroidism and Hyperthyroidism

  • Raynaud's Disease

  • Autoimmune disorders: Lupus (SLE), Sjogren's Syndrome, Hashimoto's thyroiditis and Grave's DiseaseCREST SyndromeSclerodermaCeliac Disease and Ulcerative Colitis (UC)Psoriasis/Psoriatic ArthritisRheumatoid Arthritis (RA), Multiple Sclerosis (MS) and Neuromyelitis optica (NMO)

bottom of page